3.1.1. Lifestyle Modifications will be recommended such as healthy eating and quitting smoking and drinking alcohol. 3.2.

The association between hospital-diagnosed migraine and increased risks to cardiovascular health cannot be attributed to NSAID use.

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which proceeds slowly and cannot be ...

In this randomized controlled trial, in older adults with non-ST-segment elevation myocardial infarction (NSTEMI), invasive ...

Financially, Verve has a market cap of $475mn, cash balance of $540mn, and a cash runway of 7-8 quarters. Find out my ...

A new study supports previous data demonstrating the superiority of prasugrel over ticagrelor in reducing the composite ...

Whether you should be on heart attack medication depends on your medical history, such as having high blood pressure. Find a ...

Novo Nordisk said Wednesday that Wegovy is the first Health Canada-approved treatment for both chronic weight management and to reduce the risk of non-fatal myocardial infarction. The treatment ...

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

or history of myocardial infarction or stroke]); and (3) secondary prevention of cardiovascular disease (CVD; aged 45 years or older, BMI ≥27 kg/m 2, and a history of myocardial infarction or ...